When harmful bacteria or other microorganisms invade the body, neutrophils, a type of white blood cell, are one of the first immune cells to respond. They release powerful weapons to trap and kill ...

Phase 3 results revealed Monday led shares to surge and should yield an approval application in IgA nephropathy, a ...

A Kennedy Krieger Institute researcher is playing a role in a major international effort that has yielded a promising ...

With updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug ...

Panelists discuss how patient-reported outcomes including symptom burden, treatment-related adverse effects, preserved functionality, and impact on quality of life should be prioritized alongside ...